logowsbdaily | Thu, 21 Oct 2021 07:34:38 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Amyris, Inc.
(AMRS)

Amyris, Inc.
5885 Hollis Street
Suite 100
EmeryVille, CA 94608
United States
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration... Read More

Summary & Charts

Price$ 12.25+0.20 (+1.65%)
Day's Range$ 12.07 - 12.62 
Previous Close$ 12.05
Market Cap$ 4.33B USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqGS
IndustrySpecialty Chemicals
SectorBasic Materials
Volume4.55M
Avg. Volume (20 day)2.87M
Rel. Volume (20 day)1.73
Rel. Volume (3 month)1.69
RatingBNeutral
DCFN/AStrong Buy
Debt/Equity-432.80 %Strong Sell
ROE241.05 %Sell
ROA-93.32 %Neutral
P/E-8.26 %Strong Buy
P/B-27.66 %Strong Sell
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Oct 13, 2021$ 12.48$ 12.62$ 12.07$ 12.61+0.365,200,9941.731.692
Oct 12, 2021$ 12.13$ 12.45$ 12.05$ 12.25+0.204,554,9001.591.521
Oct 11, 2021$ 12.10$ 12.68$ 12.00$ 12.05+0.083,113,1071.131.055
Oct 08, 2021$ 12.20$ 12.25$ 11.96$ 11.97-0.201,827,9420.670.622
Oct 07, 2021$ 12.16$ 12.73$ 12.02$ 12.17+0.143,139,3151.121.062
Oct 06, 2021$ 12.35$ 12.40$ 11.73$ 12.03-0.602,206,7380.790.75
Oct 05, 2021$ 12.77$ 13.11$ 12.42$ 12.63-0.122,180,8980.760.71
Oct 04, 2021$ 13.69$ 13.82$ 12.59$ 12.75-1.163,214,7341.101.051
Oct 01, 2021$ 13.86$ 14.05$ 13.32$ 13.91+0.182,261,2080.760.74
Sep 30, 2021$ 13.59$ 13.93$ 13.45$ 13.73+0.172,230,6350.730.711
Sep 29, 2021$ 13.81$ 13.83$ 13.09$ 13.56-0.092,712,7050.880.861
Sep 28, 2021$ 14.47$ 14.56$ 13.63$ 13.65-0.963,425,6281.121.081
Sep 27, 2021$ 14.23$ 14.94$ 13.99$ 14.61+0.563,446,5661.121.093
Sep 24, 2021$ 13.65$ 14.55$ 13.65$ 14.05+0.545,063,9591.661.613
Sep 23, 2021$ 13.37$ 13.60$ 13.00$ 13.51+0.283,023,1001.040.972
Sep 22, 2021$ 13.46$ 13.58$ 13.06$ 13.23-0.251,939,2800.660.62
Sep 21, 2021$ 12.99$ 13.49$ 12.97$ 13.48+0.601,886,6580.620.602
Sep 20, 2021$ 13.20$ 13.72$ 12.67$ 12.88-0.863,129,8650.990.99
Sep 17, 2021$ 13.54$ 13.88$ 13.35$ 13.74+0.153,050,5850.930.963
Sep 16, 2021$ 13.21$ 13.59$ 12.85$ 13.59+0.302,499,9140.760.791

News

The latest news about Amyris, Inc. (AMRS).

InvestorPlace | 2021-10-04 12:57:40
Sin stocks are considered defensive and tend to remain more stable under tough economic conditions. Here are the top ones to watch in 2021.
PRNewsWire | 2021-09-22 08:00:00
EMERYVILLE, Calif., Sept. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in the Clean Health, Beauty and Wellness markets, today announced that it will host its fourth virtual investor webinar on Tuesday, September 28, 2021.
PRNewsWire | 2021-08-26 08:30:00
EMERYVILLE, Calif., Aug. 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of JVN™, a clean hair products brand.
Seeking Alpha | 2021-08-20 21:43:41
Amryris will lead the ESG growth space for years to come. Amyris is providing a sustainable growth solution that will continue to be impactful.
The Motley Fool | 2021-08-20 15:51:30
The company announced promising results from a study of its experimental intranasal COVID-19 vaccine.
PRNewsWire | 2021-08-20 08:00:00
EMERYVILLE, Calif., Aug. 20, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI).
Forbes | 2021-08-19 10:27:27
The Dow Jones dropped around 145 points or 0.4%, the S&P 500 fell 0.4%, and the Nasdaq dipped 0.5%. Find opportunities in today's market with today's best short plays from Q.ai's artificial intelligence.

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2021-11-03BMO-0.15----64M----
2021-08-05BMO-0.13-0.1623.07%53M52M-1.26%
2021-05-06BMO-0.02-1.085300%73M177M141.08%
2021-03-02BMO-0.09-0.44388.88%69M80M14.83%
2020-11-05BMO-0.17-0.41141.17%14M34M141.17%
2020-08-06BMO-0.19-0.56194.73%10M30M194.73%
2020-05-08BMO-0.19-0.56194.73%9.9M29M194.73%
2020-03-12AMC-0.28-0.65132.14%17M41M132.14%

Due Diligences

These posts should include more in-depth research by the poster about the specific company, sector or trade idea. Including any sources and citations.

thumbnail
AMRS- Making limited stuff unlimited (referring to your $$)

​ Sup everyone. You know how we all love Jpow? Because he just prints infinite amounts of $$$, even though common sense would tell ~~most~~ a few of us that money is logically a finite thing. But since this is not the group to be told what to do by some nerd called "common sense", I thou... Read More

51 comments | 122 votes

Top Discussions

These are the top discussions over the last 24-hours that mention the AMRS stock ticker symbol.


Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Fri, 30 Jul 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.